| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $12.2B | — | — | — | — |
| Op. Income | $1.0B | — | — | — | — |
| Gross Margin | 39.9% | — | — | — | — |
| Net Margin | 1.1% | — | — | — | — |
| EPS (Diluted) | $4.09 | — | — | — | — |
| Free Cash Flow | $447M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $12.2B |
| Cost of Revenue | $7.3B |
| GROSS PROFIT | $4.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $3.9B |
| Other Expenses | $0 |
| Operating Expenses | $3.9B |
| Cost & Expenses | $11.2B |
| OPERATING INCOME | $1.0B |
| Interest Income | $108M |
| Interest Expense | $311M |
| Other Income/Expenses | -$291M |
| INCOME BEFORE TAX | $725M |
| Income Tax Expense | $215M |
| Net Income from Continuing Ops | $510M |
| Net Income from Discontinued Ops | -$179M |
| Other Adjustments | $0 |
| NET INCOME | $137M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $137M |
| D&A | $722M |
| EBIT | $1.0B |
| EBITDA | $1.8B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $12.2B |
| Cost of Revenue | $7.3B |
| GROSS PROFIT | $4.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $3.9B |
| Other Expenses | $0 |
| Operating Expenses | $3.9B |
| Cost & Expenses | $11.2B |
| OPERATING INCOME | $1.0B |
| Interest Income | $108M |
| Interest Expense | $311M |
| Other Income/Expenses | -$291M |
| INCOME BEFORE TAX | $725M |
| Income Tax Expense | $215M |
| Net Income from Continuing Ops | $510M |
| Net Income from Discontinued Ops | -$179M |
| Other Adjustments | $0 |
| NET INCOME | $137M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $137M |
| D&A | $722M |
| EBIT | $1.0B |
| EBITDA | $1.8B |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $298M |
| Depreciation & Amortization | $683M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$43M |
| Other Non-Cash Items | $139M |
| Change in Working Capital | -$70M |
| OPERATING CASH FLOW | $1.0B |
| Capital Expenditure | -$560M |
| Acquisitions (Net) | $92M |
| Purchases of Investments | $17M |
| Sales/Maturities of Investments | $709M |
| Other Investing Activities | $4M |
| NET CASH FROM INVESTING | $178M |
| Net Debt Issuance | -$208M |
| Common Stock Repurchased | -$11M |
| Common Dividends Paid | -$745M |
| Other Financing Activities | -$399M |
| NET CASH FROM FINANCING | -$1.4B |
| FREE CASH FLOW | $447M |
| Net Change in Cash | -$128M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $6.7B |
| Short-Term Investments | $0 |
| Net Receivables | $4.1B |
| Inventory | $3.5B |
| Other Current Assets | $1.9B |
| TOTAL CURRENT ASSETS | $16.2B |
| PP&E (Net) | $15.6B |
| Goodwill | $2.3B |
| Intangible Assets | $5.6B |
| Long-Term Investments | $2.2B |
| Tax Assets | $1.7B |
| Other Non-Current Assets | $454M |
| TOTAL NON-CURRENT ASSETS | $27.9B |
| TOTAL ASSETS | $44.1B |
| Account Payables | $4.8B |
| Short-Term Debt | $1.8B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $3.8B |
| TOTAL CURRENT LIABILITIES | $12.1B |
| Long-Term Debt | $7.1B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $514M |
| Other Non-Current Liabilities | $1.4B |
| TOTAL NON-CURRENT LIABILITIES | $14.2B |
| TOTAL LIABILITIES | $26.2B |
| Common Stock | $156M |
| Additional Paid-In Capital | -$668M |
| Retained Earnings | $14.7B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$830M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $13.4B |
| Minority Interest | $4.5B |
| TOTAL EQUITY | $17.9B |
| TOTAL LIABILITIES & EQUITY | $44.1B |
| Total Debt | $14.0B |
| Net Debt | $7.3B |
